Efficacy and safety of venetoclax in patients with relapsed/refractory multiple myeloma: a meta-analysis

被引:0
作者
Xiaohui Gao
Hui Zeng
Xiaoyan Zhao
Haibing Wu
Minchao Yan
Yuan Li
Gang Zhang
Fei Sun
机构
[1] The Affiliated Hospital of Jiaxing University,Departments of Pediatrics
[2] The Affiliated Hospital of Jiaxing University,Departments of Hematology
来源
BMC Cancer | / 23卷
关键词
Venetoclax; Multiple Myeloma; Efficacy; Adverse events; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
[31]   Efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma: a real-life experience [J].
Soyer, Nur ;
Patir, Pusem ;
Uysal, Ayse ;
Duran, Mustafa ;
Unal, Hatice Demet ;
Durusoy, Raika ;
Tombuloglu, Murat ;
Sahin, Fahri ;
Tobu, Mahmut ;
Vural, Filiz ;
Saydam, Guray .
TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (04) :777-785
[32]   Carfilzomib for the treatment of patients with relapsed and/or refractory multiple myeloma [J].
Stewart, A. Keith .
FUTURE ONCOLOGY, 2015, 11 (15) :2121-2136
[33]   Efficacy and safety of subcutaneous versus intravenous bortezomib in multiple myeloma: a meta-analysis [J].
Hu, Bin ;
Zhou, Quan ;
Wu, Tao ;
Zhuang, Lan ;
Yi, Liping ;
Cao, Jinxia ;
Yang, Xin ;
Wang, Jun .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (04) :329-338
[34]   Efficacy and safety of daratumumab in the treatment of multiple myeloma: a systematic review and meta-analysis [J].
Wang, Yin ;
Li, Yanqing ;
Chai, Ye .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (08)
[35]   Real-world safety and efficacy of teclistamab in relapsed/refractory multiple myeloma: results from a multicenter, retrospective study and descriptive meta-analysis [J].
Varma, Gaurav ;
Fogel, Lindsay ;
Gordon, Beth ;
Saldarriaga, Mateo Mejia ;
Ahn, Jaeil ;
Aleman, Adolfo ;
Caro, Jessica ;
Rosenberg, Maya C. ;
Monge, Jorge ;
Parmar, Harsh ;
Kaminetzky, David ;
Moskovits, Tibor ;
Siegel, David S. ;
Morgan, Gareth J. ;
Niesvizky, Ruben ;
Davies, Faith E. ;
Biran, Noa .
LEUKEMIA & LYMPHOMA, 2025, 66 (05) :942-951
[36]   Efficacy and Safety of Panobinostat in Relapsed or/and Refractory Multiple Myeloma: Meta Analyses of Clinical Trials and Systematic Review [J].
Liu, Jing-di ;
Sun, Chun-yan ;
Tang, Liang ;
Wu, Ying-ying ;
Wang, Qing-yun ;
Hu, Bei ;
Hu, Yu .
SCIENTIFIC REPORTS, 2016, 6
[37]   Efficacy and Safety of triplet versus doublet regimens in patients with multiple myeloma: A systematic review and meta-analysis [J].
Meng, Zilu ;
Zheng, Hanxue ;
Li, Yanhong ;
Bai, Jun ;
Zhang, Liansheng ;
Li, Lijuan .
CURRENT PROBLEMS IN CANCER, 2025, 56
[38]   Safety and Efficacy of Teclistamab in Patients with Relapsed/ Refractory Multiple Myeloma: A Real-World Experience [J].
Dima, Danai ;
Davis, James A. ;
Ahmed, Nausheen ;
Jia, Xuefei ;
Sannareddy, Aishwarya ;
Shaikh, Hira ;
Shune, Leyla ;
Kaur, Gurbakhash ;
Khouri, Jack ;
Afrough, Aimaz ;
Strouse, Christopher ;
Lochner, Jonathan ;
Mahmoudjafari, Zahra ;
Raza, Shahzad ;
Valent, Jason ;
Anderson Jr, Larry D. ;
Anwer, Faiz ;
Abdallah, Al-Ola ;
Hashmi, Hamza .
TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (03) :308.e1-308.e13
[39]   Comparative efficacy and safety of BCMA-targeted CAR T cells and BiTEs in relapsed/refractory multiple myeloma: a meta-analysis of interventional and real-world studies [J].
Techaapornkun, Pisanupong ;
Rojpalakorn, Waranyoo ;
Mejun, Nuthchaya ;
Khaniya, Asmita ;
Thammahong, Arsa ;
Thu, May Soe ;
Hirankarn, Nattiya ;
Pitakkitnukun, Palada .
ANNALS OF HEMATOLOGY, 2025,
[40]   Safety and efficacy of pomalidomide, dexamethasone and pegylated liposomal doxorubicin for patients with relapsed or refractory multiple myeloma [J].
Cohen, Alexa ;
Spektor, Tanya M. ;
Stampleman, Laura ;
Bessudo, Alberto ;
Rosen, Peter J. ;
Klein, Leonard M. ;
Woliver, Thomas ;
Flam, Marshall ;
Eshaghian, Shahrooz ;
Nassir, Youram ;
Maluso, Tina ;
Swift, Regina A. ;
Vescio, Robert ;
Berenson, James R. .
BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (01) :60-70